Clinical Trial Update: A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET [Phase 2]

View source ↗

Summary

A single-arm Phase 2 study evaluating P1101 in adults with essential thrombocythemia; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia

Drugs mentioned

• P1101

Snippet

Sponsor: PharmaEssentia | Conditions: Essential Thrombocythemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING